- Sorted by date
- Hybrid Sort
- Smart Random Sort
- Sort by relevance
Advertisements
» Related Searches: breast cancer, lung cancer, prostate cancer, cancer, drug
Results 11 to 20 of 68 
Bad news for top-selling anemia drug
A new medical study suggests that high doses of a best-selling drug used to treat
anemia in dialysis and cancer patients may increase the risk of heart problems and
death … 
FDA OKs Genentech drug for early breast cancer
LOS ANGELES (Reuters) - The U.S. Food and Drug Administration has agreed to expand
the use of Genentech Inc.'s breast cancer drug Herceptin to include women with
early-stage cancer who …
Drug Might Squeeze Out Bone Cancer
THURSDAY, Nov. 16 (HealthDay News) -- An experimental drug prevented bone tumors in
50 percent of mice in a preclinical study, researchers report …
November 16, 2006: In the News
The seizure drug Lyrica may offer extended pain relief for people with fibromyalgia,
new research finds. Patients given higher does of a drug to treat anemia and
cancer have an …
FDA to Widen Use of Late-Stage Breast Cancer Drug
The drug Herceptin has been used to treat late-stage breast cancer for some
time, and today the Food and Drug Administration is expected to officially widen its
use. Tests of …
Hope for a more effective and less toxic cancer drug
Detailed evaluation conducted at WEHI into a possible new cancer drug suggests that
it may prove to be more effective and less toxic than current chemotherapeutic drugs …
FDA Mulls New Breast Cancer Therapy
The Food and Drug Administration may be on the verge of approving a new use for
Herceptin, a bioengineered drug used to treat breast cancer. The Early Show
medical correspondent …
Researchers study new strategy for attacking cancer cells
Filed under: Drug, Chemotherapy, All Cancers, Research All cells in our body are
programmed to die. They have a limited lifespan and they die when they are damaged, worn
out …
New Reata cancer drug reduces tumors
Reata Pharmaceuticals has presented preclinical data showing that its investigatonal
drug candidate RTA 402 prevented the development of lung cancer in a mouse model
of the disease …
Synta skin cancer drug granted fast track
Synta Pharmaceuticals has said its oncology drug candidate, STA-4783, has been
granted fast track designation by the FDA for the treatment of metastatic melanoma, a
serious type of skin cancer …